captopril has been researched along with Cirrhoses, Experimental Liver in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bridle, KR; Campbell, CM; Clouston, AD; Crawford, DH; de Guzman, CE; Jaskowski, LA; Nathan Subramaniam, V; Santrampurwala, N; Sobbe, AL | 1 |
| Bayram, I; Ozbek, H; Tuncer, I; Ugras, S | 1 |
| Ahn, SC; Baik, SK; Cho, MY; Choi, YH; Kim, CH; Kim, JW; Kim, MY; Kwon, SO; Park, DH; Rhim, DW | 1 |
| Goissis, G; Montenegro, AP; Ramos, SG; Rossi, MA | 1 |
| Brabant, G; Brunkhorst, R; Koch, KM; Malcharzik, C; Wrenger, E | 1 |
| Arrizurieta, E; Galcerán, T; Ibarra, FR; Oddo, E | 1 |
| Murray, BM; Paller, MS | 1 |
7 other study(ies) available for captopril and Cirrhoses, Experimental Liver
| Article | Year |
|---|---|
Lack of efficacy of mTOR inhibitors and ACE pathway inhibitors as antifibrotic agents in evolving and established fibrosis in Mdr2⁻/⁻ mice.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Sub-Family B Member 4; Biphenyl Compounds; Captopril; Drug Therapy, Combination; Everolimus; Female; Gene Expression Regulation; Hydroxyproline; Irbesartan; Liver; Liver Cirrhosis, Experimental; Male; Mice, Knockout; Protein Kinase Inhibitors; Renin-Angiotensin System; Signal Transduction; Sirolimus; Species Specificity; Tetrazoles; Time Factors; TOR Serine-Threonine Kinases | 2015 |
Anti-fibrogenic effects of captopril and candesartan cilexetil on the hepatic fibrosis development in rat. The effect of AT1-R blocker on the hepatic fibrosis.
Topics: Actins; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Captopril; Carbon Tetrachloride; Cell Count; Disease Models, Animal; Immunohistochemistry; Liver; Liver Cirrhosis, Experimental; Male; Rats; Rats, Sprague-Dawley; Tetrazoles; Treatment Outcome | 2003 |
[Inhibitory effect of angiotensin blockade on hepatic fibrosis in common bile duct-ligated rats].
Topics: Actins; Angiotensin II Type 1 Receptor Blockers; Animals; Bile Ducts; Captopril; Fibrosis; Hydroxyproline; Ligation; Liver; Liver Cirrhosis, Experimental; Losartan; Male; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta | 2007 |
Captopril reduces collagen and mast cell and eosinophil accumulation in pig serum-induced rat liver fibrosis.
Topics: Animals; Blood; Captopril; Collagen; Eosinophils; Liver Cirrhosis, Experimental; Male; Mast Cells; Rats; Rats, Wistar; Swine | 1994 |
Renal effects of atrial natriuretic peptide in cirrhotic rats with and without captopril pretreatment.
Topics: Animals; Atrial Natriuretic Factor; Captopril; Carbon Tetrachloride; Glomerular Filtration Rate; Kidney; Liver Cirrhosis, Experimental; Male; Natriuresis; Rats; Renal Circulation; Renin-Angiotensin System | 1993 |
Changes in glomerular filtration rate and renal plasma flow in cirrhotic rats during converting enzyme inhibition.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Glomerular Filtration Rate; Liver Cirrhosis, Experimental; Liver Function Tests; Male; Rats; Rats, Wistar; Renal Plasma Flow; Renin-Angiotensin System; Water-Electrolyte Balance | 1998 |
Decreased pressor reactivity to angiotensin II in cirrhotic rats. Evidence for a post-receptor defect in angiotensin action.
Topics: Angiotensin II; Animals; Blood Pressure; Captopril; Dose-Response Relationship, Drug; Liver Cirrhosis, Experimental; Male; Meclofenamic Acid; Norepinephrine; Pressoreceptors; Rats; Rats, Inbred Strains; Receptors, Angiotensin; Receptors, Cell Surface | 1985 |